Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efavirenz-based HIV regimen comparison for lipodystrophy and adipocyte mitochondrial DNA
2005-004021-26Phase 4Completed
- Sponsor
- University Hospitals Birmingham
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in human immunodeficiency virus infection (HIV) comparing Combivir + Sustiva with Truvada + Sustiva (2 arms). Primary endpoints: Plasma lipids, Insulin resistance and 5 more. Started Sep 2005; status: completed.
02
Drugs
efavirenzlamivudine + zidovudineemtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2005-004021-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004021-26.